Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
出版年份 2018 全文链接
标题
Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-5
出版商
Informa UK Limited
发表日期
2018-02-27
DOI
10.1080/21645515.2018.1445448
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dengue vaccine safety signal: Immune enhancement, waning immunity, or chance occurrence?
- (2017) Bradford D. Gessner et al. VACCINE
- ADE and dengue vaccination
- (2017) Ruth Aralí Martínez-Vega et al. VACCINE
- Dengue vaccine: WHO position paper, July 2016 – recommendations
- (2017) World Health Organization VACCINE
- Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge
- (2016) Scott B. Halstead AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
- (2016) Gustavo Olivera-Botello et al. JOURNAL OF INFECTIOUS DISEASES
- Critique of World Health Organization Recommendation of a Dengue Vaccine
- (2016) Scott B. Halstead JOURNAL OF INFECTIOUS DISEASES
- Dengue Vaccine Efficacy: Not a Zero Sum Game
- (2016) Scott B. Halstead JOURNAL OF INFECTIOUS DISEASES
- Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine
- (2016) Annelies Wilder-Smith et al. JOURNAL OF INFECTIOUS DISEASES
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
- (2016) Neil M. Ferguson et al. SCIENCE
- Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
- (2016) Laurent Coudeville et al. VACCINE
- Protective and immunological behavior of chimeric yellow fever dengue vaccine
- (2016) Scott B. Halstead et al. VACCINE
- The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
- (2016) Stefan Flasche et al. PLOS MEDICINE
- Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials
- (2016) Anke Harenberg et al. PLoS Neglected Tropical Diseases
- Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
- (2016) Philip K. Russell et al. PLoS Neglected Tropical Diseases
- Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
- (2015) Bruno Guy et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- “Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
- (2008) Robert Edelman et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started